Trial intelligence / Profile preview

Impact of the Level of Neuromuscular Blockade on Surgical Conditions in Laparoscopic Bariatric Surgery

NCT02118844Phase 4Unknown

Sponsor
CHRU de Nancy - Hôpital Central
Start
Jul 2014
Primary completion
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rocuronium in class III obesity, sponsored by CHRU de Nancy - Hôpital Central. Status: unknown.

02

Drugs

rocuronium
03

Conditions

class III obesity

Beyond the preview

Go deeper on NCT02118844.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02118844.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call